>> 全站文章索引 >> 第18页:
  • Sulpiride in Combination with Fluvoxamine Increases in vivo Dopamine Release Selectively in Rat Prefrontal Cortex - [Yukio Ago1, Shigeo Nakamura1, Akemichi Baba2 and Toshio Matsuda1]
  • Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brain - [S. B. Sartori, P. W. J. Burnet, T. Sharp and N. Singewald]
  • Clinical trial data: to disclose or not to disclose? - [Aaron Bouchie]
  • Differential effects of simultaneous or sequential administration of paroxetine and WAY-100,635 on ejaculatory behavior - [C. Looney, K.B. Thor, D. Ricca and L. Marson]
  • Dopaminergic mechanism of antidepressant action in depressed patients - [Paul Willner, Anthony S. Hale and Spilios Argyropoulos]
  • Do mood disorders alter crying a pilot investigation - [Rottenberg J, Cevaal A, Vingerhoets AJ.]
  • Effects of chronic paroxetine pretreatment on (±)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior - [T.R. de Jong, T. Pattij, J.G. Veening, P.J.W.C. Dederen, M.D. Waldinger, A.R. Cools and B. Olivier]
  • Withdrawal symptoms from paroxetine - [Colin Milliken 1, Stephen J. Cooper 2 * AD:1Department of Psychiatry, Belfast City Hospital, Belfast, UK2Department of Mental Health, The Queen]
  • Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors - [Centorrino, Franca, Baldessarini, Ross J, et al]
  • Effect of acute and chronic administration of caffeine on pain-like behaviors in rats with partial sciatic nerve injury - [Wu WP, Hao JX, Fredholm BB, Wiesenfeld-Hallin Z, Xu XJ.]
  • Modification of presynaptic CaM kinase II affinity for ATP in hippocampus after long term blockade of serotonin reuptake - [Elena Consogno, Cinzia Dorigo, Giorgio Racagni and Maurizio Popoli]
  • Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression - [Laszlo Gyulai1, Charles L Bowden2, Susan L McElroy3, Joseph R Calabrese4, Frederick Petty5, Alan C Swann6, James C-Y Chou7,8, Adel Wassef6, Craig S Risch9, Robert M A Hirschfeld10, Charles B Nemeroff11, Paul E Keck Jr3, Dwight L Evans1 and Patricia J Wozn]
  • Serotonin and Dopamine Transporter Availabilities Correlate with the Loudness Dependence of Auditory Evoked Potentials in Patients with Obsessive-Compulsive Disorder - [Oliver Pogarell1, Klaus Tatsch2, Georg Juckel1, Christine Hamann2, Christoph Mulert1, Gabriele P?pperl2, Malte Folkerts1, Martina Choukèr2, Michael Riedel1, Michael Zaudig3, Hans-Jürgen M?ller1 and Ulrich Hegerl1]
  • Medical and psychiatric casualties caused by conventional and radiological (dirty) bombs - [Hall RC, Hall RC, Chapman MJ.]
  • Disability and its treatment in bipolar disorder patients - [Huxley N, Baldessarini RJ.]
  • Collaborative Management of Women with Bipolar Disorder During Pregnancy and Postpartum-Pharmacologic Considerations - [Ward S, Wisner KL.]
  • PHARMAC and treatment of bipolar depression—the limits of utilitarianism - [Ellis P, Mulder R, Porter R.]
  • Pharmacogenetics and bipolar disorder - [F Mamdani1, I Jaitovich Groisman1, M Alda1 and G Turecki1]
  • Serotonin and its transporter on proliferation of fetal heart cells - [Youssef Sari and Feng C. Zhou]
  • Acute angle closure glaucoma associated with paroxetine - [S J Benbow, G Gill]
  • The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4 - [Su SY, Chen JJ, Lai CC, Chen CM, Tsai FJ.]
  • Do venlafaxine XR and paroxetine equally influence negative and positive affect? - [Gabriel S. Dichter, Andrew J. Tomarken, Cathryn M. Freid, Stephanie Addington and Richard C. Shelton]
  • A Comparison of the Chronic Treatment Effects of Venlafaxine and Other Antidepressants on Serotonin and Norepinephrine Transporters - [Georgianna G. Gould, Alfonso V. Altamirano, Martin A. Javors and Alan Frazer]
  • Interferon-alpha–induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment - [Lucile Capuron, Gabriele Neurauter, Dominique L. Musselman, David H. Lawson, Charles B. Nemeroff, Dietmar Fuchs and Andrew H. Miller]
  • Comparison of Fluoxetine and Paroxetine in Type II Diabetes Mellitus Patients - [Leyla Gülseren, Seref Gülseren, Zeliha Hekimsoy and Levent Mete]
  • Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation - [Graziano Pinna, Oliver Broedel, Murat Eravci, Gisela Stoltenburg-Didinger, Hanna Plueckhan, Sandra Fuxius, Harald Meinhold and Andreas Baumgartner]
  • Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study - [Marc J. Kaufman, Michael E. Henry, Blaise deB. Frederick, John Hennen, Rosemond A. Villafuerte, Eve P. Stoddard, Mark E. Schmidt, Bruce M. Cohen and Perry F. Renshaw]
  • Altered Brain Activation Pattern Associated With Drug-Induced Attenuation of Enhanced Depression-Like Behavior in Rats Bred for High Anxiety - [Patrik Muigg, Ulrike Hoelzl, Klara Palfrader, Inga Neumann, Alexandra Wigger, Rainer Landgraf and Nicolas Singewald]
  • Methodologic pitfalls in measurement of 5-hydroxytriptamine uptake transporters in human platelets by [3H]-paroxetine binding assay - [Noé Jurado, Carlos Torner, Gerhard Heinze, Guadalupe López, José Mendoza-Sotelo, Alejandro Lazo-Langner and Julia Moreno]
  • Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures - [Vikram K. Yeragani, Vanessa Pesce, Anusha Jayaraman and Steven Roose]
  • Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis - [Emilio J Sanz, Carlos De-las-Cuevas, Anne Kiuru, Andrew Bate and Ralph Edwards]
  • Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data - [Craig J Whittington, Tim Kendall, Peter Fonagy, David Cottrell, Andrew Cotgrove and Ellen Boddington]
  • Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension - [Steven M. Kawut, Evelyn M. Horn, Ketevan K. Berekashvili, David J. Lederer, Allison C. Widlitz, Erika B. Rosenzweig and Robyn J. Barst]
  • The apolipoprotein E 4 allele and antidepressant efficacy in cognitively intact elderly depressed patients - [Greer M. Murphy, Charlotte Kremer, Heidi Rodrigues and Alan F. Schatzberg]
  • Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder - [Damiaan Denys, Sjoerd Fluitman, Annemieke Kavelaars, Cobi Heijnen and Herman G.M. Westenberg]
  • A comparative study of milnacipran and paroxetine in outpatients with major depression - [Daniel Sechter, Pierre Vandel, Emmanuel Weiller, Nicole Pezous, Fabienne Cabanac and Alain Tournoux]
  • Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption - [Manfred Uhr, Markus T. Grauer and Florian Holsboer]
  • Cerebral blood volume and clinical changes on the third day of placebo substitution for SSRI treatment - [Michael E. Henry, Marc J. Kaufman, John Hennen, David Michelson, Mark E. Schmidt, Eve Stoddard, Alexander J. Vukovic, Paul J. Barreira, Bruce M. Cohen and Perry F. Renshaw]
  • The effect of pharmacotherapy on personality disorders in panic disorder: A one year naturalistic study - [Carlo Marchesi, Alessandro Cantoni, Stefania Fontò, Maria R. Giannelli and Carlo Maggini]
  • Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression - [Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Shusuke Numata, Sawako Kinouchi, Sumiko Tayoshi-Shibuya, Hongwei Song and Tetsuro Ohmori]
  • Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors - [Akira Kugaya, Gerard Sanacora, Julie K. Staley, Robert T. Malison, Ali Bozkurt, Shaukat Khan, Amit Anand, Christopher H. van Dyck, Ronald M. Baldwin, John P. Seibyl, et al.]
  • Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference? - [Alejandra Pinto-Meza, Judith Usall, Antoni Serrano-Blanco, David Suárez and Josep Maria Haro]
  • Regulation of the norepinephrine transporter by chronic administration of antidepressants - [Saloua Benmansour, Alfonso V. Altamirano, David J. Jones, Teresa A. Sanchez, Georgianna G. Gould, Marie-Christine Pardon, David A. Morilak and Alan Frazer]
  • Effect of Chronic Administration of Duloxetine on Serotonin and Norepinephrine Transporter Binding Sites in Rat Brain - [Georgianna G. Gould, Martin A. Javors and Alan Frazer]
  • Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder - [Eric Vermetten, Meena Vythilingam, Steven M. Southwick, Dennis S. Charney and J. Douglas Bremner]
  • Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder - [Martin Keller, Stuart Montgomery, William Ball, Mary Morrison, Duane Snavely, Guanghan Liu, Richard Hargreaves, Jarmo Hietala, Christopher Lines, Katherine Beebe, et al.]
  • Comparison of first refill rates among users of sertraline, paroxetine, and citalopram - [C. Daniel Mullins, Fadia T. Shaya, Fanlun Meng, Junling Wang and Morgan S. Bron]
  • Duloxetine hydrochloride: A new dual-acting medication for the treatment of major depressive disorder - [Melanie E. Hunziker, Brandon T. Suehs, Tawny L. Bettinger and M. Lynn Crismon]
  • A survey of prescribing practices in the treatment of depression - [Timothy Petersen, Christina Dording, Nicole B. Neault, Rebecca Kornbluh, Jonathan E. Alpert, Andrew A. Nierenberg, Jerrold F. Rosenbaum and Maurizio Fava]
  • Longitudinal Study of Regional Cerebral Blood Flow Changes in Depression After Stroke - [Yamaguchi, Shuhei M.; Kobayashi, Shotai M.; Koide, Hiromi M.; Tsunematsu, Tokugoro M.]
  • Influences of Hyperbaric Oxygen on Blood Pressure, Heart Rate and Blood Glucose Levels in Patients with Diabetes Mellitus and Hypertension - [Al-Waili NS, Butler GJ, Beale J, Abdullah MS, Finkelstein M, Merrow M, Rivera R, Petrillo R, Carrey Z, Lee B, Allen M.]
  • Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism? - [Thomas I. F. H. Cremers, Loes J. Wiersma, Fokko J. Bosker, Johan A. den Boer, Ben H. C. Westerink and H?kan V. Wikstr?m]
  • A Depressed Myocardium - [Samuel J. Partridge, David H. MacIver, Tarun Solanki]
  • Chinese herbal medicine for schizophrenia - [Rathbone J, Zhang L, Zhang M, Xia J, Liu X, Yang Y.]
  • Three year naturalistic outcome study of panic disorder patients treated with paroxetine - [Dannon PN, Iancu I, Cohen A, Lowengrub K, Grunhaus L, Kotler M.]
  • The Effects of Olanzapine,Risperidone,and Haloperidol on Plasma Prolactin Levels in Patients with Schizophrenia - [David SR, Taylor CC, Kinon BJ, Breier A.]
  • Depression after stroke and lesion location: a systematic review - [Carson, Alan J.; MacHale, Siobhan; Allen, Kathryn; Lawrie, Stephen M.; Dennis, Martin; House, Allan; Sharpe, Michael]
  • A Communication Strategy and Brochure for Relatives of Patients Dying in the ICU - [Lautrette A, Darmon M, Megarbane B, Joly LM, Chevret S, Adrie C, Barnoud D, Bleichner G, Bruel C, Choukroun G, Curtis JR, Fieux F, Galliot R, Garrouste-Orgeas M, Georges H, Goldgran-Toledano D, Jourdain M, Loubert G, Reignier J, Saidi F, Souweine B, Vince]
  • Bupropion and paroxetine differentially influence cardiovascular and neuroendocrine responses to stress in depressed patients - [Patricia A. Straneva-Meuse, Kathleen C. Light, Michael T. Allen, Michael Golding and Susan S. Girdler]
  • Antidepressants for smoking cessation - [Hughes JR, Stead LF, Lancaster T.]
  • Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures - [Carolyn S. Dewa, Jeffrey S. Hoch and Paula Goering]
  • Problem solving skills for schizophrenia - [Xia J, Li C.]
  • Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder - [Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder]
  • Immune response in addicts with chronic hepatitis C treated - [Sergio N, Salvatore T, Gaetano B, Davide P, Claudio I, Massimo L, Barbara M, Giuseppe A, Stefano C, Danila C, Aikaterini T, Luca I, Daniela C, Luciano C.]
  • Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients - [Basso M, Torre F, Grasso A, Percario G, Azzola E, Artioli S, Blanchi S, Pelli N, Picciotto A.]
  • A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder - [Paola Rocca, Valeria Fonzo, Luigi Ravizza, Giuseppe Rocca, Monica Scotta, Enrico Zanalda and Filippo Bogetto]
  • Use of sertraline, paroxetine and fluvoxamine by nursing women - [Hendrick V, Fukuchi A, Altshuler L, Widawski M, Wertheimer A, Brunhuber MV.]
  • Paroxetine binding to the rat norepinephrine transporter in vivo - [Michael J. Owens, David L. Knight and Charles B. Nemeroff]
  • New generation antipsychotics for first episode schizophrenia - [Rummel C, Hamann J, Kissling W, Leucht S.]
  • The serotonin transporter in the midbrain of suicide victims with major depression - [William Bligh-Glover, Tamara N. Kolli, Laura Shapiro-Kulnane, Ginny E. Dilley, Lee Friedman, Elizabeth Balraj, Grazyna Rajkowska and Craig A. Stockmeier]
  • Indications for antidepressant drug prescribing in general practice in the Netherlands - [Gardarsdottir H, Heerdink ER, van Dijk L, Egberts AC.]
  • A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction - [Aben, I.; Verhey, F.; Strik, J.; Lousberg, R.; Lodder, J.; Honig, A.]
  • What Is Worse for Asthma Control and Quality of Life-Depressive Disorders,Anxiety Disorders,or Both - [Lavoie KL, Bacon SL, Barone S, Cartier A, Ditto B, Labrecque M]
  • Residual Anxiety Symptoms in Depressed Primary Care Patients - [McIntyre RS, Konarski JZ, Soczynska JK, Kennedy SH.]
  • Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder Changes in Weight With Long-Term Treatment - [Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC.]
  • Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer - [Morales L, Canney P, Dyczka J, Rutgers E, Coleman R, Cufer T, Welnicka-Jaskiewicz M, Nortier J, Bogaerts J, Therasse P, Paridaens R; European Organisation for Research and Treatment of Cancer Breast Group; Scottish Breast Cancer Trials Group.]
  • Psychosocial and psychological interventions for preventing postpartum depression - [Dennis CL, Creedy D.]
  • A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder - [Jeffrey S. McCombs, Lizheng Shi, Glen L. Stimmel and Thomas W. Croghan]
  • The relationship between generalized anxiety disorder,depression and mortality in old age - [Holwerda TJ, Schoevers RA, Dekker J, Deeg DJ, Jonker C, Beekman AT.]
  • Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder - [Peter Berger, Gabriele Sachs, Michaela Amering, Anita Holzinger, Bettina Bankier and Heinz Katschnig]
  • Brain metabolic changes associated with symptom factor improvement in major depressive disorder - [Arthur L. Brody, Sanjaya Saxena, Mark A. Mandelkern, Lynn A. Fairbanks, Matthew L. Ho and Lewis R. Baxter]
  • Suicidality in middle aged and older patients with schizophrenia and depressive symptoms- relationship to functioning and Quality of Life - [Kasckow J, Montross L, Golshan S, Mohamed S, Patterson T, Sollanzano E, Zisook S.]
  • Assessment of physical etiologies for mood and anxiety disorders in structured diagnostic interviews - [Patten SB, Williams JV.]
  • Stroke, vascular risk factors and depression: Cross-sectional study in a UK Caribbean-born population - [STEWART, R.; PRINCE, M.; RICHARDS, M.; BRAYNE, C.; MANN, A.]
  • Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram - [S. J. Wilson, J. E. Bailey, A. S. Rich, M. Adrover, J. Potokar and D. J. Nutt]
  • Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine - [Michael J. Owens, David L. Knight and Charles B. Nemeroff]
  • Premedication for anxiety in adult day surgery - [Smith AF, Pittaway AJ.]
  • Strategies for managing sexual dysfunction induced by antidepressant medication - [Rudkin L, Taylor MJ, Hawton K.]
  • Depressive Symptoms and Increased Risk of Stroke Mortality Over a 29-Year Period - [Everson, Susan A.; Roberts, Robert E.; Goldberg, Debbie E.; Kaplan, George A.]
  • A comparison of citalopram and paroxetine in the treatment of panic disorder-a randomized, single-blind study - [Perna G, Bertani A, Caldirola D, Smeraldi E, Bellodi L.]
  • Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose - [Geoffrey K. Isbister, Steven J. Bowe, Andrew Dawson, et al.]
  • Interventions for helping people recognise early signs of recurrence in bipolar disorder - [Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP]
  • Is There a Continuity between Bipolar and Depressive Disorders - [Benazzi F.]
  • Mood and thyroid immunity assessed by ultrasonographic imaging in a primary health care - [Bunevicius R, Peceliuniene J, Mickuviene N, Bunevicius A, Pop VJ, Girdler SS.]
  • Depression–anxiety relationships with chronic physical conditions Results from the World Mental Health surveys - [Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, Benjet C, Bromet E, de Girolamo G, de Graaf R, Gasquet I, Gureye O, Haro JM, He Y, Kessler RC, Levinson D, Mneimneh ZN, Oakley Browne MA, Posada-Villa J, Stein DJ, Takeshima T, Von Korff M]
  • Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker - [Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH, Messerli FH, Oparil S, Schork MA; Trial of Preventing Hypertension (TROPHY) Study Investigators.]
  • Managing the symptoms of multiple sclerosis-A multimodal approach - [Crayton HJ, Rossman HS.]
  • Depression among older people with cognitive impairment：prevalence and detection - [McCabe MP, Davison T, Mellor D, George K, Moore K, Ski C.]
  • The role of patient personality in the identification of depression in older primary care patients - [McCray LW, Bogner HR, Sammel MD, Gallo JJ.]
  • Adjunctive Lamotrigine Treatment for Adolescents with Bipolar Disorder-Retrospective Report of Five Cases - [Soutullo CA, Díez-Suárez A, Figueroa-Quintana A.]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 [18] 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50